Is there a role for anticonvulsants in the management of rheumatic pain?
Bannwarth
Bernard
B
D000588:Amines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D005356:Fibromyalgia / Q000188:drug therapy; D000077206:Gabapentin; D006801:Humans; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000069583:Pregabalin; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*; D012219:Rheumatology / Q000379:methods*; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin